Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial
Nicola Benjamin (Heidelberg, Germany), Nicola Benjamin, Hans Klose, Mona Lichtblauf, Johannes Weidenhammer, Christine Fischer, Robert Nechwatal, Sören Uiker, Michael Halank, Karen Olsson, Werner Seeger, Henning Gall, Stephan Rosenkranz, Heinrike Wilkens, Dirk Mertens, Hans-Jürgen Seyfarth, Christian Opitz, Silvia Ulrich, Benjamin Egenlauf, Ekkehard Grünig
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicola Benjamin (Heidelberg, Germany), Nicola Benjamin, Hans Klose, Mona Lichtblauf, Johannes Weidenhammer, Christine Fischer, Robert Nechwatal, Sören Uiker, Michael Halank, Karen Olsson, Werner Seeger, Henning Gall, Stephan Rosenkranz, Heinrike Wilkens, Dirk Mertens, Hans-Jürgen Seyfarth, Christian Opitz, Silvia Ulrich, Benjamin Egenlauf, Ekkehard Grünig. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial. Eur Respir J 2016; 48: Suppl. 60, 267
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014
Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013
Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial Source: Eur Respir J 2010; 35: 571-577 Year: 2010
Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016
Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
Effects of a 3-week pulmonary rehabilitation program in patients with idiopathic pulmonary fibrosis – A randomized, controlled trial Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases Year: 2016
Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013
An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013
Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN) Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013
Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study Source: Eur Respir J 2006; 27: 697-704 Year: 2006
Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016
Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure - a randomized, controlled, double-blind, crossover trial Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020
Dexamethasone reduces pulmonary artery pressure in lowlanders with COPD travelling to 3200m. A randomized, placebo-controlled trial Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016
Inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study): A multicentre randomised controlled trial Source: International Congress 2016 – Best abstracts on the role of exercise and physical activity in chronic respiratory disease Year: 2016
Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013
Effects of additional manual therapy over inspiratory muscle training in patients with chronic obstructive pulmonary disease: A randomized controlled trial Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015
Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013